In March of 2020, private practices, physician groups, and hospital systems began to significantly reduce (or even eliminate) face-to-face interactions between healthcare professionals (HCPs) and representatives from industry manufacturers in response to the accelerating spread of COVID-19.
Seemingly overnight, pharmaceutical and medical device companies had to pivot toward engaging with HCPs, and delivering educational content, almost exclusively through digital outreach channels.
For this infographic, we asked physicians, physicians assistants, and nurse practitioners from our industry-leading healthcare database to help us understand how their interactions with representatives from pharmaceutical and medical device manufacturers have evolved over the two-plus years since the beginning of COVID-19. The following provides insights on how HCPs are currently engaging with educational content and opportunities from the healthcare industry, and how they expect to do so in the future.